Skip to main content
. 2022 Oct 25;65(1):e73. doi: 10.1192/j.eurpsy.2022.2328

Table 3.

Defined daily doses (DDDs) of prescribed psychopharmacologic drugs in Austria in the months March to December in 2019 and 2020.

Total Females Males
2019/03–12 2020/03–12 2019/03–12 2020/03–12 2019/03–12 2020/03–12
Total 291,722,002 286,450,149 −1.8% 182,832,460 179,872,718 −1.6% 108,888,844 106,576,663 −2.1%
Antidepressants (N06A) 178,777,672 177,707,840 −0.6% 118,669,761 118,279,653 −0.3% 60,107,583 59,427,419 −1.1%
Antipsychotics (N05A) 31,624,152 31,896,314 0.9% 16,111,898 16,249,260 0.9% 15,512,254 15,647,054 0.9%
Anxiolytics (N05B) and hypnotics (N05C) 32,721,180 29,532,437 −9.7% 18,500,862 16,616,733 −10.2% 14,220,318 12,915,704 −9.2%
Antidementia drugs (N06D) 42,523,158 41,094,775 −3.4% 27,969,087 27,098,848 −3.1% 14,553,991 13,995,927 −3.8%
Others (N06B and N07B) 6,075,840 6,218,783 2.4% 1,580,852 1,628,224 3.0% 4,494,698 4,590,559 2.1%